Hinova Pharmaceuticals Inc. (SHA:688302)
China · Delayed Price · Currency is CNY 40.05
-0.95 (-2.32%)
At close: Jun 2, 2026
Hinova Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -135.03 | -137.25 | -199.5 | -294.16 | -301.51 | -306.18 |
Depreciation & Amortization | 7.24 | 7.24 | 5.97 | 6.42 | 5.47 | 3.05 |
Other Amortization | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.63 |
Loss (Gain) From Sale of Assets | - | - | 0 | 0.01 | 0 | 0 |
Loss (Gain) From Sale of Investments | -15.35 | -15.35 | -13.11 | -24.83 | -28.89 | -23.56 |
Provision & Write-off of Bad Debts | 0 | 0 | - | - | - | - |
Other Operating Activities | 22.16 | 0.25 | -3.66 | -2.78 | -3.3 | 6.05 |
Change in Accounts Receivable | 1.35 | 1.35 | 5.92 | 5.76 | 4.04 | 3.96 |
Change in Inventory | -2.84 | -2.84 | 0 | 0 | -0 | -0 |
Change in Accounts Payable | 28.99 | 28.99 | -7.54 | -21.85 | -93.6 | -20.6 |
Change in Other Net Operating Assets | 8.68 | 8.68 | 24.79 | 75.88 | 102.82 | 108.82 |
Operating Cash Flow | -84.75 | -108.88 | -187.08 | -255.51 | -314.92 | -227.82 |
Capital Expenditures | -64.46 | -82.89 | -89.55 | -99.18 | -69.21 | -19.77 |
Sale of Property, Plant & Equipment | 0 | 0 | 0 | 0.02 | 0 | - |
Investment in Securities | 290 | -100 | 80 | -25 | -370 | - |
Other Investing Activities | 27.43 | 43.18 | -20.7 | 24.83 | 29.31 | 23.2 |
Investing Cash Flow | 252.97 | -139.7 | -30.25 | -99.33 | -409.9 | 3.42 |
Short-Term Debt Issued | - | - | - | 0.5 | 30 | - |
Long-Term Debt Issued | - | 100 | - | - | - | - |
Total Debt Issued | 100 | 100 | - | 0.5 | 30 | - |
Short-Term Debt Repaid | - | - | - | -30.5 | - | -0.5 |
Long-Term Debt Repaid | - | -3.52 | -4.06 | -4.39 | -3.4 | -1.56 |
Total Debt Repaid | -3.52 | -3.52 | -4.06 | -34.89 | -3.4 | -2.06 |
Net Debt Issued (Repaid) | 96.48 | 96.48 | -4.06 | -34.39 | 26.6 | -2.06 |
Issuance of Common Stock | - | - | - | - | 1,010 | - |
Common Dividends Paid | -1.88 | -1.24 | - | -0.9 | - | -2.56 |
Other Financing Activities | 0.26 | - | - | - | -19.31 | -3.86 |
Financing Cash Flow | 94.85 | 95.24 | -4.06 | -35.29 | 1,017 | -8.48 |
Foreign Exchange Rate Adjustments | -3.86 | -2.29 | 1.43 | 1.75 | 7.8 | -1.99 |
Net Cash Flow | 259.21 | -155.64 | -219.96 | -388.38 | 300.38 | -234.87 |
Free Cash Flow | -149.21 | -191.76 | -276.63 | -354.68 | -384.13 | -247.6 |
Free Cash Flow Margin | -320.91% | -936.81% | -75410.46% | - | -23269.07% | - |
Free Cash Flow Per Share | -1.51 | -1.94 | -2.79 | -3.58 | -4.23 | -3.33 |
Cash Interest Paid | - | - | - | - | 3.92 | - |
Cash Income Tax Paid | 1.09 | 1.12 | 0.44 | -19.4 | -13.46 | -6.07 |
Levered Free Cash Flow | -53.46 | -203.51 | -159.1 | -230.86 | -252.88 | -145.13 |
Unlevered Free Cash Flow | -53.33 | -203.29 | -158.77 | -229.93 | -250.43 | -143.54 |
Change in Working Capital | 36.19 | 36.19 | 23.17 | 59.79 | 13.27 | 92.19 |